Dayron Ortega
Endocrinology, Diabetes & Metabolism · Miami, FLNPI 1437684693
Payments from drug & device makers
Across 61 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$247
- Dexcom, Inc.$216
- Corcept Therapeutics$192
- Xeris Pharmaceuticals, Inc.$164
- Amgen$136
- Insulet Corporation$63
- plus $402 from 14 others
What the payments were for
- Food & beverage$1,37597%
- Education$453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $247 |
| Dexcom, Inc. | 6 | $216 |
| Corcept Therapeutics | 4 | $192 |
| Xeris Pharmaceuticals, Inc. | 9 | $164 |
| Amgen(2 entities) | 8 | $136 |
| Insulet Corporation | 3 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $55 |
| Bayer | 3 | $53 |
| Novo Nordisk | 2 | $45 |
| Recordati_rare_diseases_inc. | 2 | $43 |
| Merck | 2 | $41 |
| Novartis | 1 | $24 |
| Medtronic | 1 | $23 |
| Mannkind Corporation | 1 | $20 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Nevro Corp. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$146
- DEXCOM G7 GSS (161)$125
- RETEVMO$111
How this compares
$1,420 in reported general payments places this provider in the 30th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Other endocrinology, diabetes & metabolism in Miami
- Rodolfo GalindoMiami$2.5M
- Eugenio Angueira-SerranoMiami$2.2M
- Jay SkylerMiami$2.2M
- Camillo RicordiMiami$1.4M
- Gianluca IacobellisMiami$346K
- Carlos BarreraMiami$157K
- Marilu JuradoMiami$146K
- Richard PratleyOrlando$9.2M
- Jose MandryOcoee$9.1M
- Steven SmithOrlando$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.